Second Sight Medical Products

$1.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-2.84%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell EYES and other stocks, options, and ETFs commission-free!

About EYES

Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. It operates through the following geographical segments: United States, Italy, France, and China. The firm's product include Argus II Retinal Prosthesis System that treats outer retinal degenerations, such as retinitis pigmentosa, also referred to as RP. The company was founded by Alfred E. Mann, Aaron Mendelsohn, Sam Williams, Robert J. Greenberg, and Gunnar Bjorg in 1998 and is headquartered in Sylmar, CA. The listed name for EYES is Second Sight Medical Products, Inc. Common Stock.

CEO
Matthew J. Pfeffer
Employees
112
Headquarters
Sylmar, California
Founded
1998
Market Cap
41.05M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.49M
High Today
$1.77
Low Today
$1.66
Open Price
$1.75
Volume
972.72K
52 Week High
$6.40
52 Week Low
$0.6906

Collections

EYES Earnings

-$0.49
-$0.33
-$0.16
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 18, After Hours

You May Also Like

BIO.B
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure